The Role of Double Strand Breaks in Carcinogenesis
The Role of Double Strand Breaks in Carcinogenesis
批准号:
6858676
负责人:
CHRISTOPHER J KEMP
金额:
$38.49万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-10 至 2007-03-31
关键词:
BCL2 gene /proteinDNA damageSCID mouseantineoplasticsapoptosisbiological signal transductionenzyme activityepitheliumgene induction /repressiongene interactiongene mutationgene targetinggenetically modified animalsgenotypeionizing radiationlaboratory mouseliver neoplasmsmutantneoplastic processnuclear factor kappa betap53 gene /proteinphosphatidylinositol 3 kinaseradiation carcinogenesisradiation geneticsskin neoplasmstissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (PROVIDED BY APPLICANT) The induction of p53 and apoptosis in
response to ionizing radiation and other stressors in vivo varies greatly
between normal tissues, between cell types within a tissue, and between tumor
types. Our long-term goal is to understand the basis of this tissue
specificity. One approach is to analyze the tissue specificity of the p53
response pathway in genetic mutants of putative upstream regulators of p53,
notably the P13K family members DNAPK and Atm. These analyses have shown that
in response to gamma radiation (1) DNAPK is not required to upregulate p53 or
apoptosis. In fact, mutation in DNAPK sensitizes cells, even p53 null cells, to
apoptosis. This demonstrates a novel DNAPK dependent anti-apoptotic pathway.
(2) Atm is required to upregulate p53 and apoptosis in some tissue, but is not
required in all tissues such as epithelium indicating there are compensatory
pathways to regulate p53 and apoptosis and the relative importance of these
compensatory pathways varies between tissue types. (3) DNAPK and Atm
functionally collaborate in that simultaneous mutation in both genes results in
synthetic lethality early in embryogenesis. We propose to (1) determine if
mutation in DNAPK can also radiosensitize p53 null tumor cells and to
characterize this novel DNAPK dependent anti-apoptotic pathway, (2) determine
if DNAPK, Atm and Atr are redundant in regulating p53 and apoptosis in vivo,
(3) determine the morphologic and cellular basis of lethality of DNAPK Atm
compound mutant embryos, and if altered regulation of p53 or apoptosis
contributes to this defect. Understanding the functional interaction of the P13
Ks, in regulating p53, apoptosis, development and carcinogenesis at the level
of the whole animal is a necessary link to apply knowledge gained from cell
culture models to the clinic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Pip4k2c and Pip5k1b dependencies in Ras driven squamous cell carcinoma
-
批准号:10667117
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2023
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
A Patient-Centric Approach to Advance Functional Precision Oncology
-
批准号:10721205
-
项目类别:
-
资助金额:$109.88万
-
财政年份:2023
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Personalized cancer models to discover and develop new therapeutic targets.
-
批准号:10228567
-
项目类别:
-
资助金额:$47.03万
-
财政年份:2017
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Personalized cancer models to discover and develop new therapeutic targets.
-
批准号:10602920
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2017
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
-
批准号:10295144
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2017
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Personalized cancer models to discover and develop new therapeutic targets.
-
批准号:9767101
-
项目类别:
-
资助金额:$82.14万
-
财政年份:2017
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
-
批准号:10601428
-
项目类别:
-
资助金额:$45.67万
-
财政年份:2017
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
-
批准号:10049232
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2017
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
An integrated computational and functional genomics discovery engine for preclini
-
批准号:8495704
-
项目类别:
-
资助金额:$108.88万
-
财政年份:2013
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
An integrated computational and functional genomics discovery engine for preclini
-
批准号:8685205
-
项目类别:
-
资助金额:$101.3万
-
财政年份:2013
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Mouse Models of Tumor Progression and Therapy Response
-
批准号:6588223
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Mouse Models of Tumor Progression and Therapy Response
-
批准号:6700274
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Mouse Models of Tumor Progression and Therapy Response
-
批准号:7190502
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Mouse Models of Tumor Progression and Therapy Response
-
批准号:7008483
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2003
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
Mouse Models of Tumor Progression and Therapy Response
-
批准号:6850653
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
The Role of Double Strand Breaks in Carcinogenesis
-
批准号:6436226
-
项目类别:
-
资助金额:$38.04万
-
财政年份:1996
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
DOUBLE STRAND BREAKS AND CARCINOGENESIS
-
批准号:2700674
-
项目类别:
-
资助金额:$27.61万
-
财政年份:1996
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
The Role of Double Strand Breaks in Carcinogenesis
-
批准号:6621729
-
项目类别:
-
资助金额:$38.49万
-
财政年份:1996
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
DOUBLE STRAND BREAKS AND CARCINOGENESIS
-
批准号:2414455
-
项目类别:
-
资助金额:$26.4万
-
财政年份:1996
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
The Role of Double Strand Breaks in Carcinogenesis
-
批准号:6727659
-
项目类别:
-
资助金额:$38.49万
-
财政年份:1996
-
负责人:CHRISTOPHER J KEMP
-
依托单位:
海外基金